Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-06

Clinical Trial Update: Allogeneic Stem Cell Therapy in Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of allogeneic stem cell therapy in heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allogeneic stem cell therapy

Snippet

Sponsor: JKastrup | Conditions: Heart Failure | Phase 2 | Status: COMPLETED